The University of Chicago Header Logo

Connection

John Moroney to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications John Moroney has written about Dose-Response Relationship, Drug.
John Moroney
Connection Strength
0.072
Dose-Response Relationship, Drug
  1. A phase I trial of liposomal doxorubicin, bevacizumab, and temsirolimus in patients with advanced gynecologic and breast malignancies. Clin Cancer Res. 2011 Nov 01; 17(21):6840-6.
    View in: PubMed
    Score: 0.072
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.